[opensourcepharma] More reading material

[Matthew Todd]

All,

In case you didn't see this today (Twitter people will have)

A Dearth in Innovation for Key Drugs
<http://www.nytimes.com/2014/07/23/business/a-dearth-of-investment-in-much-needed-drugs.html?smid=tw-share&_r=0>,
in the NYT, which links out to

An overview of FDA-approved new molecular entities: 1827-2013
<http://www.sciencedirect.com/science/article/pii/S1359644614001032> in
Drug Discovery Today, March 2014

Best,

Mat


-- 
MATTHEW TODD | Associate Professor
School of Chemistry | Faculty of Science

THE UNIVERSITY OF SYDNEY
Rm 519, F11 | The University of Sydney | NSW | 2006
T +61 2 9351 2180  | F +61 2 9351 3329  | M +61 415 274104
E matthew.todd at sydney.edu.au | W
http://sydney.edu.au/science/chemistry/research/todd.html | W
http://opensourcemalaria.org/

CRICOS 00026A
This email plus any attachments to it are confidential. Any unauthorised
use is strictly prohibited. If you receive this email in error, please
delete it and any attachments.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20140724/6702023c/attachment.html>